Home
Sana Biotechnology, Inc.

Sana Biotechnology, Inc. Market Share Analysis for August 2026

Our privacy policy.

Computers Electronics and Technology > Graphics Multimedia and Web Design

Domainsana.com

Year Founded2018

Employees201 - 500

Annual Revenue$100M - $200M

Sana Biotechnology, Inc.

Sana Biotechnology, Inc. (including company regionals)

sana.com

See more website traffic and engagement information

Sana Biotechnology, Inc. Revenue up to August 2026 is 100M - 200M

revenue generated by Sana Biotechnology, Inc. top domains

Sana Biotechnology, Inc. top domains revenue over 3 years

Revenue for Sana Biotechnology, Inc. top domains

sana.com100M - 200M

See more with Sales Intelligence

Total visits to Sana Biotechnology, Inc.'s top domains

Understand Sana Biotechnology, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sana.com22.6K

See more with Sales Intelligence

Avg. visit duration in Sana Biotechnology, Inc.'s top domains

Analyze Sana Biotechnology, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sana.com00:00:57

See more with Sales Intelligence

Avg. pageviews on Sana Biotechnology, Inc.'s top domains

See how Sana Biotechnology, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sana.com2.74

See more with Sales Intelligence

Sana Biotechnology, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

cellares.comCompany NameCellares CorporationEmployees51 - 200HQUnited States, California, South San FranciscoAnnual revenue$2M - $5MTotal visits22.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sana Biotechnology, Inc.

These are the website technologies, by industry, used by Sana Biotechnology, Inc. top domains

Advertising (8)

PubMatic

Conversion & Analytics (6)

Google Analytics

Email Services (3)

Microsoft Exchange Online

Social (3)

AddThis

More Technologies

9

See all

News & Signals from Sana Biotechnology, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSana Biotechnology, Inc. is developing SC451 on Jul 1st '26.Sana's scalable development candidate, SC451, uses stem-cell-derived islets and still has to prove that a therapeutic dose can restore normal glucose control in a formal clinical trial.

NewsSana Biotechnology, Inc. is developing engineered-cell therapies for cancer and genetic diseases on Aug 14th '26.Institutional investors own 88.23% of the company, while Sana continues developing engineered-cell therapies for cancer and genetic diseases.

NewsSana Biotechnology, Inc. is developing SC451 on Jul 14th '26.Sana now plans to advance SC451, a stem cell-derived, hypoimmune islet therapy intended to provide a scalable, one-time treatment for T1D without lifelong immunosuppression.